An AI system capable of diagnosing stroke and selecting patients for surgical treatment is currently being tested in Moscow, the mayor of the capital, Sergei Sobyanin, said in his telegram channel. It was developed by the doctors of the I.V. Davydovsky City Clinical Hospital together with the Moscow innovation company as part of a grant program supported by the Moscow Center for Innovative Technologies in Healthcare.
The system analyzes CT and MRI data, helping doctors diagnose stroke more accurately. It acts as an assistant and warns about possible risks, reducing the likelihood of diagnostic errors.
Sobyanin stated that the system is integrated into the hospital’s local digital infrastructure, enabling rapid and accurate decisions regarding the necessity and effectiveness of surgery for ischemic stroke, as well as offering optimal patient management strategies.
Pilot tests of the AI system were conducted at the stroke center of the I.V. Davydovsky City Clinical Hospital. Once its effectiveness is clinically confirmed, the technology is scheduled to be expanded across the entire stroke network in Moscow.
Earlier, Sobyanin stated that doctors at the Morozov Children’s City Clinical Hospital conducted Russia’s first industrial-scale CAR-T therapy on a 12-year-old patient admitted with a recurrence of acute lymphoblastic leukemia. The mayor said the drug was manufactured at a pharmaceutical plant and purchased at the expense of a grant from the Moscow government.
